Despite numerous major changes looming in the healthcare industry, the 2015 edition of the Great American Physician Survey found that U.S. physicians are still happy in their careers.
Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from PMSS and XANTUS, real-world safety studies of rivaroxaban (Xarelto) in people with non-valvular atrial fibrillation (NVAF). The results found the rates and patterns of major bleeding in routine clinical practice were low (2.89 and 2.1 per 100 person-years, respectively) and generally consistent with those observed in Phase 3 clinical research.
A drug-eluting coronary stent made of absorbable material performed similarly to gold-standard metal among patients with an ST-segment elevation myocardial infarction (STEMI), according to results of the ABSORB STEMI TROFI II trial.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Gene transfer therapy to correct an enzyme abnormality involved in myocardial contraction and relaxation did not improve outcomes in heart failure patients with reduced ejection fraction, results of the CUPID 2 study show.
The Centers for Medicare & Medicaid Services (CMS) announced the creation of the Medicare Advantage Value-Based Insurance Design Model, designed to improve care and reduce costs in Medicare Advantage plans.
Sorin Group announced the start of patient enrollment in its TRIUMPH-CRT clinical trial in Europe.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Most patients with a cardiac resynchronization therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented at the European Society of Cardiology (ESC) Congress.
Results of the PLATFORM trial indicate fractional flow reserve computed tomography (FFR-CT) can obviate the need for invasive tests in up to 61 percent of patients with chest pain and suspected coronary artery disease. The results were presented at the European Society of Cardiology (ESC) Congress 2015.
Hospital-based healthcare providers today are under greater pressure than ever to administer cost- and time-efficient ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
An investigational material known as Bioabsorbable Cardiac Matrix (BCM), designed to prevent cardiac remodeling in heart attack patients, had no significant effect compared to a saline placebo, according to a new study.
September 2, 2015 — HeartWare International Inc. announced it entered into a definitive agreement to acquire Valtech ...
Retrieval of larger thrombi during intra-arterial treatment (IAT) is associated with improved neurological recovery after acute ischemic stroke, according to a sub-study of the MR CLEAN trial.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Findings presented at the European Society of Cardiology (ESC) Congress 2015 indicate that a small left ventricle with thick walls is the strongest predictor of morphologic remodeling in chronic ischemic heart disease patients.
Emergency department patients with chest pain suggestive of acute myocardial infarction (AMI) can be triaged more quickly and safely using a new rapid assay with refined cut-offs, German research suggests.
Automated alerts for excess fluid accumulation in the lungs did not improve outcomes for heart failure patients with implantable cardioverter defibrillators (ICDs), according to results of the OPTILINK HF trial.
September 04, 2015
